Patient Website | CARVYKTI® (ciltacabtagene autoleucel)

Meta Data Analysis

Description	Learn about CARVYKTI®, a type of CAR-T cell therapy for adult patients. See Safety & Prescribing information, including Boxed Warning.
h1 tags	In a clinical study, CARVYKTI® reduced the risk of disease progression or passing away by 59% compared with standard therapy.
h2 tags	View video transcript View video transcript View video transcript
Site Speed	0.56232595443726

Alexa Rank:	0
Site's Traffic

Host	Type	Class	TTL	Target
carvykti.com	HINFO	IN	1800